These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 24011578)

  • 1. Epigenetics of progression of chronic kidney disease: fact or fantasy?
    Wing MR; Ramezani A; Gill HS; Devaney JM; Raj DS
    Semin Nephrol; 2013 Jul; 33(4):363-74. PubMed ID: 24011578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic Modification Mechanisms Involved in Inflammation and Fibrosis in Renal Pathology.
    Morgado-Pascual JL; Marchant V; Rodrigues-Diez R; Dolade N; Suarez-Alvarez B; Kerr B; Valdivielso JM; Ruiz-Ortega M; Rayego-Mateos S
    Mediators Inflamm; 2018; 2018():2931049. PubMed ID: 30647531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methylation profile associated with rapid decline in kidney function: findings from the CRIC study.
    Wing MR; Devaney JM; Joffe MM; Xie D; Feldman HI; Dominic EA; Guzman NJ; Ramezani A; Susztak K; Herman JG; Cope L; Harmon B; Kwabi-Addo B; Gordish-Dressman H; Go AS; He J; Lash JP; Kusek JW; Raj DS;
    Nephrol Dial Transplant; 2014 Apr; 29(4):864-72. PubMed ID: 24516231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic Modification Drives Acute Kidney Injury-to-Chronic Kidney Disease Progression.
    Li Z; Li N
    Nephron; 2021; 145(6):737-747. PubMed ID: 34419948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical relevance of epigenetic dysregulation in chronic kidney disease-associated cardiovascular disease.
    Zawada AM; Rogacev KS; Heine GH
    Nephrol Dial Transplant; 2013 Jul; 28(7):1663-71. PubMed ID: 23512108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are Alterations in DNA Methylation Related to CKD Development?
    Rysz J; Franczyk B; Rysz-Górzyńska M; Gluba-Brzózka A
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGFβ-incurred epigenetic aberrations of miRNA and DNA methyltransferase suppress Klotho and potentiate renal fibrosis.
    Yin S; Zhang Q; Yang J; Lin W; Li Y; Chen F; Cao W
    Biochim Biophys Acta Mol Cell Res; 2017 Jul; 1864(7):1207-1216. PubMed ID: 28285987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcription factors and epigenetic modulation: its therapeutic implication in chronic kidney disease.
    Hayashi K; Itoh H
    Arch Immunol Ther Exp (Warsz); 2015 Jun; 63(3):193-6. PubMed ID: 25503375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic Changes in the Acute Kidney Injury-to-Chronic Kidney Disease Transition.
    Nangaku M; Hirakawa Y; Mimura I; Inagi R; Tanaka T
    Nephron; 2017; 137(4):256-259. PubMed ID: 28595179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulated miR-101 inhibits acute kidney injury-chronic kidney disease transition by regulating epithelial-mesenchymal transition.
    Zhao JY; Wang XL; Yang YC; Zhang B; Wu YB
    Hum Exp Toxicol; 2020 Dec; 39(12):1628-1638. PubMed ID: 32633566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current epigenetic aspects the clinical kidney researcher should embrace.
    Witasp A; Van Craenenbroeck AH; Shiels PG; Ekström TJ; Stenvinkel P; Nordfors L
    Clin Sci (Lond); 2017 Jul; 131(14):1649-1667. PubMed ID: 28667065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arsenic induces fibrogenic changes in human kidney epithelial cells potentially through epigenetic alterations in DNA methylation.
    Chang YW; Singh KP
    J Cell Physiol; 2019 Apr; 234(4):4713-4725. PubMed ID: 30191986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of genetics and epigenetics to progression of kidney fibrosis.
    Tampe B; Zeisberg M
    Nephrol Dial Transplant; 2014 Sep; 29 Suppl 4():iv72-9. PubMed ID: 23975750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic regulation of epithelial-mesenchymal transition.
    Sun L; Fang J
    Cell Mol Life Sci; 2016 Dec; 73(23):4493-4515. PubMed ID: 27392607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic regulation in the acute kidney injury to chronic kidney disease transition.
    Rodríguez-Romo R; Berman N; Gómez A; Bobadilla NA
    Nephrology (Carlton); 2015 Oct; 20(10):736-743. PubMed ID: 26015167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetics and epigenomics in diabetic kidney disease and metabolic memory.
    Kato M; Natarajan R
    Nat Rev Nephrol; 2019 Jun; 15(6):327-345. PubMed ID: 30894700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of metabolic memory on inflammation and fibrosis associated with diabetic kidney disease: an epigenetic perspective.
    Zheng W; Guo J; Liu ZS
    Clin Epigenetics; 2021 Apr; 13(1):87. PubMed ID: 33883002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose hydralazine prevents fibrosis in a murine model of acute kidney injury-to-chronic kidney disease progression.
    Tampe B; Steinle U; Tampe D; Carstens JL; Korsten P; Zeisberg EM; Müller GA; Kalluri R; Zeisberg M
    Kidney Int; 2017 Jan; 91(1):157-176. PubMed ID: 27692563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetics of kidney disease.
    Wanner N; Bechtel-Walz W
    Cell Tissue Res; 2017 Jul; 369(1):75-92. PubMed ID: 28286899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of kidney protective factors by inflammation: role of transcription factors and epigenetic mechanisms.
    Ruiz-Andres O; Sanchez-Niño MD; Moreno JA; Ruiz-Ortega M; Ramos AM; Sanz AB; Ortiz A
    Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1329-F1340. PubMed ID: 27760772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.